{
    "organizations": [],
    "uuid": "c184105077c784d891e41cbdab361b3f41371b19",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL8N1S010D",
    "ord_in_thread": 0,
    "title": "BRIEF-Molecular Partners presents preliminary results from the ongoing phase 2 study of MP0250",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 23 (Reuters) - Molecular Partners AG:\n* Said on Saturday had presented preliminary results from the ongoing phase 2 study of MP0250 at the European Myeloma Network Meeting in Turin\nSource text for Eikon:\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-23T14:55:00.000+03:00",
    "crawled": "2018-04-23T11:04:59.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "molecular",
        "partner",
        "ag",
        "said",
        "saturday",
        "presented",
        "preliminary",
        "result",
        "ongoing",
        "phase",
        "study",
        "mp0250",
        "european",
        "myeloma",
        "network",
        "meeting",
        "turin",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}